Literature DB >> 21158724

Advances in nano drugs for cancer chemotherapy.

Imran Ali1, K Salim, Mohmad A Rather, Waseem A Wani, Ashanul Haque.   

Abstract

In spite of some medications, millions of peoples are dying every year due to cancer. Additionally, the survival patients suffer from various serious side effects due to the use of available anti-neoplastic medicines. The development of nanoparticles based drugs is seems to be effective providing low side effects and targeted action on cancer cells. The present article describes the state-of-art of nano drugs in cancer chemotherapy. The nano drugs are targeted selective and specific towards tumors only resulting into better treatment. The important molecules used for preparation nano drugs are cisplatin, carboplatin, bleomycin, 5-fluorouracil, doxorubicin, dactinomycin, 6-mercaptopurine, paclitaxel, topotecan, vinblastin and etoposide etc. The most commonly used materials for preparing nanoparticles carriers are dendrimers, polymer, liposome, micelles, inorganic, organic nanoparticles etc. A survey was carried out on the drugs available in the market and given in tabular form. However, the commonly used nano drugs till date are liposome dendrimer and some other materials based nanoparticles. Attempts have been made to explain mechanism of action of nano drugs. The future perspectives have also been highlighted in to the conclusion part.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21158724     DOI: 10.2174/156800911794328493

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  22 in total

Review 1.  Overview, prevention and management of chemotherapy extravasation.

Authors:  Firas Y Kreidieh; Hiba A Moukadem; Nagi S El Saghir
Journal:  World J Clin Oncol       Date:  2016-02-10

2.  Proapoptotic chemotherapeutic drugs induce noncanonical processing and release of IL-1β via caspase-8 in dendritic cells.

Authors:  Christina Antonopoulos; Caroline El Sanadi; William J Kaiser; Edward S Mocarski; George R Dubyak
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

3.  Delivery of chemotherapeutic drugs in tumour cell-derived microparticles.

Authors:  Ke Tang; Yi Zhang; Huafeng Zhang; Pingwei Xu; Jing Liu; Jingwei Ma; Meng Lv; Dapeng Li; Foad Katirai; Guan-Xin Shen; Guimei Zhang; Zuo-Hua Feng; Duyun Ye; Bo Huang
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

4.  Cell delivery of therapeutic nanoparticles.

Authors:  JoEllyn McMillan; Elena Batrakova; Howard E Gendelman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

5.  Inhibition of hTERT Gene Expression by Silibinin-Loaded PLGA-PEG-Fe3O4 in T47D Breast Cancer Cell Line.

Authors:  Zohreh Ebrahimnezhad; Nosratollah Zarghami; Manoutchehr Keyhani; Soumaye Amirsaadat; Abolfazl Akbarzadeh; Mohammad Rahmati; Zohreh Mohammad Taheri; Kazem Nejati-Koshki
Journal:  Bioimpacts       Date:  2013-05-23

6.  Paclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of action.

Authors:  Erika N Cline; Ming-Hsin Li; Seok Ki Choi; Jeffrey F Herbstman; Neha Kaul; Edgar Meyhöfer; Georgios Skiniotis; James R Baker; Ronald G Larson; Nils G Walter
Journal:  Biomacromolecules       Date:  2013-02-21       Impact factor: 6.988

Review 7.  Nanotechnology for angiogenesis: opportunities and challenges.

Authors:  Saeid Kargozar; Francesco Baino; Sepideh Hamzehlou; Michael R Hamblin; Masoud Mozafari
Journal:  Chem Soc Rev       Date:  2020-06-15       Impact factor: 54.564

Review 8.  The physiology of cardiovascular disease and innovative liposomal platforms for therapy.

Authors:  Guillermo U Ruiz-Esparza; Jose H Flores-Arredondo; Victor Segura-Ibarra; Guillermo Torre-Amione; Mauro Ferrari; Elvin Blanco; Rita E Serda
Journal:  Int J Nanomedicine       Date:  2013-02-09

9.  ATP driven clathrin dependent entry of carbon nanospheres prefer cells with glucose receptors.

Authors:  Ruthrotha B Selvi; Snehajyoti Chatterjee; Dinesh Jagadeesan; Piyush Chaturbedy; Bangalore Srinivas Suma; Muthusamy Eswaramoorthy; Tapas K Kundu
Journal:  J Nanobiotechnology       Date:  2012-08-02       Impact factor: 10.435

10.  Porphyrins as theranostic agents from prehistoric to modern times.

Authors:  Yumiao Zhang; Jonathan F Lovell
Journal:  Theranostics       Date:  2012-09-30       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.